FULCRUM THERAPEUTICS, INC. (FULC)
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review
BGC Group to Present at the Piper Sandler Global Exchange & FinTech Conference on June 4, 2026
Heidmar Maritime Holdings Corp. Announces Transition in Chief Financial Officer Role
Merlin, Inc. To Participate in Upcoming Investor Conferences
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Broadcom Connects the AI Edge with Comprehensive Multi-Gig Broadband and Wi-Fi 8 Innovations
AAR announces participation in 2026 William Blair Growth Stock Conference
HONEYWELL APPOINTS JILL EVANKO TO BOARD OF DIRECTORS
Eaton Vance Limited Duration Income Fund, Eaton Vance Senior Floating-Rate Trust, and Eaton Vance Senior Income Trust Announce Final Results of Auction Preferred Shares Tender Offers
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)